Peptides: why scientific rigor matters more than ever

The pharmacological potency of peptides as a class demands precisely the opposite of the trivialization we observe across the wellness market today. Peter Attia emphasizes that this genuine capacity to modulate biological processes—their actual value—is exactly why they require rigorous protocol, traceability, and clinical oversight. The problem does not lie in the molecule itself but in the normalization of casual use outside controlled medical contexts. For the longevity-curious reader, the distinction is critical: access to pharmaceutical-grade peptides within supervised settings is not equivalent to self-directed consumption based on Instagram marketing. The implicit recommendation is unequivocal—any intervention potent enough to produce measurable biological change deserves to be treated as what it fundamentally is: a drug, not a supplement.